Group 1 - The briefing is focused on APRA's proposed capital standards for longevity products, with a consultation period ending on December 17th [1][3] - The company is currently engaging with APRA regarding these proposed reforms and will submit written feedback [3] - Certain topics, such as target ranges and capital allocation, will not be discussed during the session as they require approval from the Challenger Board or APRA [3] Group 2 - The event is being held at Challenger's head office in Sydney, acknowledging the traditional custodians of the land [2] - A Q&A session will follow the briefing, limited to analysts and investors who join via telephone [3] - The session aims to provide clarifications and guidance on the proposed capital standards [3]